For instance, Xu et al. have developed a seven-IRG risk signature (LCN12, CCL21, RNASE2, CGB5, NRG4, AGTR1, and NPR3) for predicting overall survival (OS) in male patients with GC [13]. The gene discussed is CGB5; the disease is gastric cancer.